Compare VNRX & LIQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VNRX | LIQT |
|---|---|---|
| Founded | N/A | 2004 |
| Country | United States | Denmark |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.5M | 20.4M |
| IPO Year | 2012 | 2011 |
| Metric | VNRX | LIQT |
|---|---|---|
| Price | $2.73 | $1.10 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | $1.67 | ★ $4.30 |
| AVG Volume (30 Days) | ★ 276.1K | 30.7K |
| Earning Date | 05-12-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 38.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,727,384.00 | N/A |
| Revenue This Year | $355.66 | $42.12 |
| Revenue Next Year | $849.08 | $63.48 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 40.04 | N/A |
| 52 Week Low | $0.13 | $1.05 |
| 52 Week High | $3.26 | $3.35 |
| Indicator | VNRX | LIQT |
|---|---|---|
| Relative Strength Index (RSI) | 65.78 | 22.77 |
| Support Level | $0.22 | N/A |
| Resistance Level | $2.89 | $2.03 |
| Average True Range (ATR) | 0.29 | 0.18 |
| MACD | -0.02 | -0.13 |
| Stochastic Oscillator | 64.18 | 3.70 |
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on diagnostics and monitoring.
LiqTech International Inc is a clean technology company which provides technology for gas and liquid purification by manufacturing ceramic silicon carbide filters. The company is renowned in three business areas: ceramic membranes and membrane incorporated liquid filtration systems, ceramic diesel particulate filters (DPFs) to control soot exhaust particles and black carbon emission from diesel engines, and plastic components for usage across various industries. The company's product portfolio consists of ceramic silicon membranes for liquid filtration, diesel particulate filters, Hybrid Technology Membranes and others. The Company operates through three reportable segments: Systems and Aftermarket, Filters and Membranes, and Components.